Metraipolis › archive › dc_b5ec2bd14283

Present and Future Post-marketing Drug Safety Assessment in Japan: A PMDA Perspective — Europe PMC PMID:42029820

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42029820
DOI
10.1007/s43441-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-10-07T23:59:09.550Z
SHA-256 of the archived text
425b664457d7584d4efed3c95bb25f70973574164ec6f7f4e1fb451a702e29fe
Stable URL of this page
https://metraipolis.com/documento/dc_b5ec2bd14283

How to cite

Present and Future Post-marketing Drug Safety Assessment in Japan: A PMDA Perspective — Europe PMC PMID:42029820 — Europe PMC (en), https://europepmc.org/article/MED/42029820 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b5ec2bd14283 (Metraipolis archive dc_b5ec2bd14283, sha256 425b664457d7584d4efed3c95bb25f70973574164ec6f7f4e1fb451a702e29fe)
BibTeX
@misc{dcb5ec2bd14283,
  title = {Present and Future Post-marketing Drug Safety Assessment in Japan: A PMDA Perspective — Europe PMC PMID:42029820},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42029820},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b5ec2bd14283; sha256 425b664457d7584d4efed3c95bb25f70973574164ec6f7f4e1fb451a702e29fe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42029820. Agents can read the archived copy with the MCP tool read_document.